Sign in
Taking people in United StatesPhase 1/2

Soy Tomato Juice to Improve Outcomes in Pancreatitis

Key facts

Who runs it
Ohio State University
Where
Columbus, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1/2
People taking part
35 people, planned
Started
2 Apr 2026
Expected to end
1 Jun 2028
Type of study
Interventional
Treatments tested
  • Soy-tomato juice product
  • Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed
Record updated
20 October 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Diagnosis of definite chronic pancreatitis (CP) or recurrent acute pancreatitis (RAP)
  • Patients should be able to fully understand and participate in all aspects of the study

Who cannot take part

  • Episode of acute pancreatitis, hospitalization, or endoscopic/surgical intervention within 30 days of enrollment
  • Chronic, daily use of systemic immunomodulatory medication for any indication
  • Previous allergic reaction to soy or tomato products
  • Known pregnancy

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Where in United States

  • The Ohio State University -Wexner Medical CenterColumbus, United StatesContact: Spencer HarrisTaking people

About the trial

What the trial wants to find out

This goal of this clinical trial is to see if people with recurrent acute pancreatitis or chronic pancreatitis can tolerate and regularly drink a tomato juice beverage. Researchers will also measure inflammation and ask participants to report how they feel. Everyone in the study will receive the tomato juice drink, and both participants and researchers will know what is being taken. The investigators expect the drink will be well tolerated, may lower inflammation, and may improve participant-reported symptoms and quality of life.

The group in the trial

  • soy-tomato juiceTreatment being tested

    4 week run-in phase where they are asked to consume a diet low in soy and lycopene, then they will receive the intervention for 4 weeks.

    Treatment: Soy-tomato juice product and Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Soy Tomato Juice to Improve Outcomes in Pancreatitis (the STOP Trial): a Phase 1/2 Single Arm Trial
Criteria questions
Built from NCT07447687, who can take part
Record updated
20 October 2026